BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17971032)

  • 1. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
    Xiang J; Gu X; Qian S; Chen Z
    Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
    Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
    Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
    Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.
    Chen J; He Q; Zhang R; Chu Y; Wang Y; Liu Q; Xiong S
    Clin Exp Immunol; 2004 Nov; 138(2):245-50. PubMed ID: 15498033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
    Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
    J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells.
    Jiga LP; Ehser S; Kleist C; Opelz G; Terness P
    Transplantation; 2007 Feb; 83(3):347-50. PubMed ID: 17297411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 12. Recipient dendritic cells modified by RNA interference targeting CD80 and CD86 elicit T cell hyporesponsiveness via enhanced T cell apoptosis.
    Hong J; Gu XD; Xiang JB; Zhang Z; Zang YW; Zhang QH; Qian SG; Chen ZY
    Chin Med J (Engl); 2013; 126(11):2139-44. PubMed ID: 23769573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S; Ahmed A; Malu S; Nandi D
    J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.
    Orabona C; Grohmann U; Belladonna ML; Fallarino F; Vacca C; Bianchi R; Bozza S; Volpi C; Salomon BL; Fioretti MC; Romani L; Puccetti P
    Nat Immunol; 2004 Nov; 5(11):1134-42. PubMed ID: 15467723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis.
    Jordan JM; Woods ME; Feng HM; Soong L; Walker DH
    J Infect Dis; 2007 Aug; 196(4):629-38. PubMed ID: 17624851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?
    Hamano K; Bashuda H; Ito H; Shirasawa B; Okumura K; Esato K
    J Surg Res; 2000 Sep; 93(1):28-34. PubMed ID: 10945940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
    Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
    Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.